Does NIVOLUMAB Cause Transfusion? 140 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 140 reports of Transfusion have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.2% of all adverse event reports for NIVOLUMAB.
140
Reports of Transfusion with NIVOLUMAB
0.2%
of all NIVOLUMAB reports
59
Deaths
103
Hospitalizations
How Dangerous Is Transfusion From NIVOLUMAB?
Of the 140 reports, 59 (42.1%) resulted in death, 103 (73.6%) required hospitalization, and 20 (14.3%) were considered life-threatening.
Is Transfusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 140 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Transfusion?
MACITENTAN (858)
VENETOCLAX (793)
APIXABAN (561)
ECULIZUMAB (454)
WARFARIN (377)
SELEXIPAG (289)
ADALIMUMAB (264)
AMBRISENTAN (244)
CEDAZURIDINE\DECITABINE (229)
EPOPROSTENOL (225)
Which NIVOLUMAB Alternatives Have Lower Transfusion Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE